<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0006302.ref022">
 <label>22</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Pripuzova</surname>
   <given-names>NS</given-names>
  </name>, 
  <name>
   <surname>Tereshkina</surname>
   <given-names>NV</given-names>
  </name>, 
  <name>
   <surname>Gmyl</surname>
   <given-names>LV</given-names>
  </name>, 
  <name>
   <surname>Dzhivanyan</surname>
   <given-names>TI</given-names>
  </name>, 
  <name>
   <surname>Rumyantsev</surname>
   <given-names>AA</given-names>
  </name>, 
  <name>
   <surname>Romanova</surname>
   <given-names>LI</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis</article-title>. 
  <source>Journal of Medical Virology</source>. 
  <year>2009</year>;
  <volume>81</volume>(
  <issue>10</issue>):
  <fpage>1777</fpage>â€“
  <lpage>85</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/jmv.21587" xmlns:xlink="http://www.w3.org/1999/xlink">10.1002/jmv.21587</ext-link>
  </comment>
  <?supplied-pmid 19697399?>
  <pub-id pub-id-type="pmid">19697399</pub-id>
 </mixed-citation>
</ref>
